Enanta Pharmaceuticals Inc
NASDAQ:ENTA

Watchlist Manager
Enanta Pharmaceuticals Inc Logo
Enanta Pharmaceuticals Inc
NASDAQ:ENTA
Watchlist
Price: 14.73 USD 4.17% Market Closed
Market Cap: 425.1m USD

Wall Street
Price Targets

ENTA Price Targets Summary
Enanta Pharmaceuticals Inc

Wall Street analysts forecast ENTA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ENTA is 19.38 USD with a low forecast of 11.11 USD and a high forecast of 29.4 USD.

Lowest
Price Target
11.11 USD
25% Downside
Average
Price Target
19.38 USD
32% Upside
Highest
Price Target
29.4 USD
100% Upside
Enanta Pharmaceuticals Inc Competitors:
Price Targets
REGN
Regeneron Pharmaceuticals Inc
7% Upside
RPTX
Repare Therapeutics Inc
43% Upside
MDGL
Madrigal Pharmaceuticals Inc
0% Upside
LVTX
LAVA Therapeutics NV
20% Downside
688266
Suzhou Zelgen Biopharmaceuticals Co Ltd
35% Upside
VCEL
Vericel Corp
56% Upside
CANTA
Cantargia AB
100% Upside
CNTB
Connect Biopharma Holdings Ltd
222% Upside

Revenue
Forecast

Revenue Estimate
Enanta Pharmaceuticals Inc

For the last 13 years the compound annual growth rate for Enanta Pharmaceuticals Inc's revenue is 4%. The projected CAGR for the next 3 years is 2%.

4%
Past Growth
2%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Enanta Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Enanta Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-32%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ENTA's stock price target?
Price Target
19.38 USD

According to Wall Street analysts, the average 1-year price target for ENTA is 19.38 USD with a low forecast of 11.11 USD and a high forecast of 29.4 USD.

What is Enanta Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
2%

For the last 13 years the compound annual growth rate for Enanta Pharmaceuticals Inc's revenue is 4%. The projected CAGR for the next 3 years is 2%.

Back to Top